Editorial Article
Optimize monoclonal antibody development with icIEF-UV/MS
Scientists at Johnson & Johnson Innovative Medicine are using the Intabio ZT system for the confident characterization of monoclonal antibodies
Field
Drug discovery > Target Discovery
Products, services, reviews and techniques used in the identification and validation of the disease-causing target genes and proteins.
Webinars
See all
Targeted protein degradation – New modalities and design technologies
Available on-demand
The role of endogenous ancestral nucleotide sequences in health and disease
Available on-demand
5 benefits of base editing to go beyond conventional CRISPR
Available on-demand
